SCHEMBL18685191

SCHEMBL18685191

Cc1cc(C(O)O)ccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
SLC6A2 P23975 1/20 0.38
CHRNB4 P30926 1/20 0.38
SLC6A4 P31645 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CHRND Q07001 1/20 0.38
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
TRPA1 O75762 1/20 0.34
PTGS1 P23219 1/20 0.34
CACNA1C Q13936 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14966985 0.84 UGT2B7 (0.45) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL14966998 0.84 UGT2B7 (0.45) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL20215798 0.79 ALDH1A1 (0.39) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL2609187 0.79 LMNA (0.52) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL14182599 0.78 TRPA1 (0.43) ALDH1A1TRPA1PTGS1CACNA1CSMN1; SMN2
SCHEMBL30965001 0.78 TSHR (0.44) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL17716410 0.78 HTR7 (0.39) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL30964940 0.78 BLM (0.47) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL16400318 0.77 CHRNA1 (0.38) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL22128459 0.77 CHRNA1 (0.41) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961745-B1 PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-03-29 EP disclosed